→The next big crisis is here (From Porter & Co.)
Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) – Oppenheimer equity analysts have upgraded Intuitive Surgical’s second quarter 2023 earnings forecast in a research note issued Wednesday, Jan. 25. Oppenheimer analyst S. Kalia now expects the medical device provider to earn $1.04 per share in the quarter, up from his previous estimate of $1.03. Intuitive Surgical’s current consensus estimate for annual earnings is $4.39 per share. Oppenheimer also forecasts third-quarter 2023 earnings of EPS of $1.10, first-quarter 2024 earnings of EPS of $1.08, second-quarter 2024 earnings of EPS of $1.16, and third-quarter 2024 earnings. at an EPS of $1.26, Q4 2024 earnings at EPS of $1.29, and 2024 earnings at EPS of $4.79.
ISRG has been the subject of several other reports. Morgan Stanley cut its price target on Intuitive Surgical stock to $265.00 from $290.00 and gave the company an “equal weight” rating in a research report Wednesday. Raymond James raised his price target on Intuitive Surgical stock from his $255.00 to his $270.00, giving it an “outperform” rating in Thursday’s research report. Wells Fargo & Company lowered its price target on Intuitive Surgical stock to $289.00 from his $305.00, and set the company’s rating to “overweight,” in a research report Wednesday. JPMorgan Chase & Co. raised Intuitive Surgical’s price target to $280.00 from his $250.00, giving the company an “Overweight” rating in a report on Friday, November 18. Finally, StockNews.com began coverage of his Intuitive Surgical stock in its Wednesday, October 12 report. They issued a “Hold” rating on the stock. Six investment analysts rated the stock with a holding rating and 14 gave the stock a buy rating. Based on MarketBeat data, the company’s current average rating is “moderate buy” with a consensus target price of $276.53.
Intuitive Surgical Trading +2.8%
NASDAQ:ISRG shares opened Friday at $250.55. The stock has a market cap of $88.54 billion, a PE ratio of 68.46, a PEG ratio of 4.67, and a beta of 1.36. The company has a 50-day moving average of $264.32 and a 200-day moving average of $234.36. Intuitive Surgical has a 12-month low of $180.07 and a 12-month high of $308.97.
Intuitive Surgical (NASDAQ:ISRG – Get Rating) last reported earnings on Tuesday, Jan. 24. The medical device provider reported his EPS of $1.23 for the quarter, missing the consensus estimate of $1.25 ($0.02). The business had revenue of $1.66 billion in the quarter, compared to consensus expectations of $1.66 billion. Intuitive Surgical’s return on equity was 11.27% and net profit margin was 21.25%. The company’s revenue for the quarter increased by 6.7% compared to the same period last year. Earnings of $1.30 per share last year.
In related news, EVP Myriam Curet sold 8,000 shares in trading on Tuesday, November 1st. The shares sold at an average price of $250.06, and the transaction totaled him $2,000,480.00. Following the closing of the transaction, the Executive Vice President now owns his 217 shares in the company, valued at his $54,263.02. The transaction was disclosed in documents filed with the SEC and available at this link. In related news, EVP Myriam Curet sold 8,000 shares in the company in a transaction that took place on Tuesday, November 1st. The shares were sold for a total of $2,000,480.00 at an average price of $250.06. After the transaction, the Executive Vice President now owns 217 shares in the company, valued at $54,263.02. The transaction is disclosed in documents filed with the SEC and available on the SEC’s website. In addition, director Amal M. Johnson sold 6,375 shares in the company on Tuesday, November 8. The shares were sold at an average price of $239.36 for a total of $1,525,920.00. Following the closing of the sale, the directors now own directly 11,224 shares of the Company’s stock valued at $2,686,576.64. Please see here for the disclosure of this sale. The insider owns his 0.90% of the company’s shares.
institution inflow and outflow
Several institutional investors and hedge funds have recently bought and sold shares in the business. RB Capital Management LLC increased his Intuitive Surgical stake by 4.4% in the first quarter. RB Capital Management LLC now owns 1,735 shares of the medical device provider worth $523,000 after acquiring an additional 73 shares during this period. Mirae Asset Global Investments Co. Ltd. increased his Intuitive Surgical holdings by 0.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 946,709 shares in the medical device provider worth $285.603 million after he purchased an additional 5,233 shares in the previous quarter. Baird Financial Group Inc. increased his Intuitive Surgical stock position by 2.3% in the first quarter. Baird Financial Group Inc. now owns 21,089 shares of the medical device provider worth $6,362,000 after purchasing an additional 481 shares during this period. Brown Brothers Harriman & Co. held 576.7% of his Intuitive Surgical shares in the first quarter. Brown Brothers Harriman & Co. now owns 406 shares worth $122,000 in the medical device provider after purchasing an additional 346 shares last quarter. Finally, Covestor Ltd boosted its Intuitive Surgical stock position by 50.4% in the first quarter. Covestor Ltd now owns 418 shares in the medical device provider valued at $126,000 after acquiring an additional 140 shares during this period. 81.96% of the shares are owned by institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures and markets the da Vinci Surgical System and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded in his November 1995 by Frederic H. Moll, John Gordon Freund and Robert G. Younge and is headquartered in Sunnyvale, California.
This instant news alert was generated by Narrative Science Technology and MarketBeat financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Send any questions or comments about this story to email@example.com.
Listen to this before considering Intuitive Surgical.
MarketBeat tracks Wall Street’s most acclaimed and top performing research analysts and the stocks they recommend to clients every day. MarketBeat identified 5 stocks top analysts are quietly whispering to clients to buy now before the broader market catches on…and Intuitive Surgical wasn’t on the list .
Intuitive Surgical currently holds a ‘moderate buy’ rating among analysts, although the highest rated analysts believe these five stocks are better buys.
See 5 stocks here
Elon Musk’s next move
When will we finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to find out when Elon Musk will finally allow these companies to IPO. Please Confirm.
Get This Free Report